Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Gomer

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|March 15, 1978
Effects of hydralazine on canine muscarinic ganglion stimulationS K Gomer, J G Hilton
European Journal of Pharmacology|December 1, 1976
Effects of hydralazines on canine muscarinic ganglion transmissionS K Gomer, J G Hilton
Immunology|March 1, 1985
Induced type-B reticulum cell neoplasia of CBA mice. I. Phenotypic similarities between tumorigenic reticulum cells and normal accessory cellsM P Brittle, M C Jacob, K Gomer, et al.
Clinical and Experimental Immunology|February 1, 1980
Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strainsM L Baltz, K Gomer, A J Davies, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|March 15, 1978
Effects of hydralazine on canine muscarinic ganglion stimulationS K Gomer, J G Hilton
European Journal of Pharmacology|December 1, 1976
Effects of hydralazines on canine muscarinic ganglion transmissionS K Gomer, J G Hilton
Immunology|March 1, 1985
Induced type-B reticulum cell neoplasia of CBA mice. I. Phenotypic similarities between tumorigenic reticulum cells and normal accessory cellsM P Brittle, M C Jacob, K Gomer, et al.
Clinical and Experimental Immunology|February 1, 1980
Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strainsM L Baltz, K Gomer, A J Davies, et al.
Pageof 1